Daré Bioscience Inc. (DARE)
NASDAQ: DARE
· Real-Time Price · USD
2.02
-0.09 (-4.27%)
At close: Aug 19, 2025, 3:59 PM
1.95
-3.70%
Pre-market: Aug 20, 2025, 04:18 AM EDT
Daré Bioscience Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2022 |
|---|---|---|
| License And Collaboration Revenues Revenue | 11M | 10M |
| License And Collaboration Revenues Revenue Growth | +10.00% | n/a |
| Royalty Revenue Revenue | 18K | n/a |
| Royalty Revenue Revenue Growth | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.38M | 2.31M | 2M | 2.04M | 2.47M | 2.66M | 2.95M | 2.7M | 2.92M | 3.34M | 3.23M | 2.65M | 2.79M | 2.57M | 2.4M | 2.21M | 1.8M | 1.94M | 1.78M | 1.35M | 1.56M | 1.86M | 1.49M | 1.45M | 1.47M | 1.39M | 1.65M | 1.18M | 1.41M | 1.4M | 15.52K | 1.05M | 3.38M | 3.59M | 2.09M | 2.37M | 2.77M | 3.12M | 2.87M | 2.95M | 2.72M | 2.68M |
| Selling, General, and Administrative Revenue Growth | +2.98% | +15.68% | -2.22% | -17.46% | -7.03% | -9.98% | +9.57% | -7.67% | -12.49% | +3.36% | +21.77% | -5.06% | +8.67% | +7.01% | +8.61% | +23.01% | -7.35% | +9.18% | +31.34% | -13.13% | -16.34% | +25.21% | +2.38% | -1.19% | +5.77% | -15.54% | +40.04% | -16.50% | +0.30% | +8942.86% | -98.53% | -68.80% | -5.91% | +71.63% | -11.96% | -14.39% | -11.06% | +8.57% | -2.78% | +8.72% | +1.34% | n/a |
| Research and Development Revenue | 1.43M | 2.3M | 3.31M | 2.66M | 4.91M | 3.33M | 3.8M | 6.67M | 6.04M | 5.02M | 12.98M | 4.46M | 6.8M | 5.8M | 7.12M | 10.43M | 7.34M | 5.73M | 6.64M | 6.2M | 5.55M | 2.38M | 2.37M | 1.97M | 2.51M | 1.69M | 1.66M | 1.45M | 2.22M | 1.09M | 672.58K | 280.79K | 1.29M | 4.65M | 3.18M | 7.09M | 7.52M | 9.77M | 7.16M | 7.09M | 6.68M | 5.02M |
| Research and Development Revenue Growth | -37.80% | -30.63% | +24.61% | -45.87% | +47.46% | -12.39% | -43.07% | +10.44% | +20.40% | -61.32% | +190.83% | -34.36% | +17.11% | -18.42% | -31.79% | +42.14% | +28.14% | -13.71% | +7.00% | +11.84% | +133.07% | +0.25% | +20.75% | -21.77% | +48.43% | +1.80% | +14.93% | -34.76% | +104.05% | +61.62% | +139.53% | -78.27% | -72.22% | +46.07% | -55.09% | -5.76% | -23.01% | +36.51% | +0.92% | +6.20% | +33.00% | n/a |